A detailed history of Cibc Asset Management Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Cibc Asset Management Inc holds 238,268 shares of AZN stock, worth $15.8 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
238,268
Previous 232,999 2.26%
Holding current value
$15.8 Million
Previous $18.2 Million 2.17%
% of portfolio
0.07%
Previous 0.07%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$76.67 - $87.62 $403,974 - $461,669
5,269 Added 2.26%
238,268 $18.6 Million
Q2 2024

Aug 01, 2024

SELL
$66.81 - $80.83 $46,967 - $56,823
-703 Reduced 0.3%
232,999 $18.2 Million
Q1 2024

May 09, 2024

BUY
$61.03 - $69.57 $615,426 - $701,543
10,084 Added 4.51%
233,702 $15.8 Million
Q4 2023

Feb 13, 2024

BUY
$61.89 - $69.28 $735,995 - $823,877
11,892 Added 5.62%
223,618 $15.1 Million
Q3 2023

Oct 30, 2023

BUY
$64.85 - $71.7 $906,473 - $1 Million
13,978 Added 7.07%
211,726 $14.3 Million
Q2 2023

Aug 14, 2023

SELL
$69.91 - $75.81 $72,217 - $78,311
-1,033 Reduced 0.52%
197,748 $14.2 Million
Q1 2023

May 12, 2023

BUY
$63.15 - $71.6 $598,156 - $678,195
9,472 Added 5.0%
198,781 $13.8 Million
Q4 2022

Feb 13, 2023

BUY
$54.21 - $70.44 $1.46 Million - $1.89 Million
26,854 Added 16.53%
189,309 $12.8 Million
Q3 2022

Nov 03, 2022

BUY
$53.02 - $135.75 $89,020 - $227,924
1,679 Added 1.04%
162,455 $8.91 Million
Q2 2022

Aug 09, 2022

SELL
$59.26 - $71.14 $256,358 - $307,751
-4,326 Reduced 2.62%
160,776 $10.6 Million
Q1 2022

May 06, 2022

BUY
$55.72 - $67.12 $3.78 Million - $4.55 Million
67,813 Added 69.7%
165,102 $11 Million
Q4 2021

Feb 08, 2022

BUY
$54.02 - $63.83 $181,561 - $214,532
3,361 Added 3.58%
97,289 $5.67 Million
Q3 2021

Nov 09, 2021

BUY
$55.56 - $60.79 $262,687 - $287,415
4,728 Added 5.3%
93,928 $5.64 Million
Q2 2021

Aug 16, 2021

BUY
$48.42 - $60.18 $343,491 - $426,916
7,094 Added 8.64%
89,200 $5.34 Million
Q1 2021

May 14, 2021

BUY
$47.16 - $54.44 $1.38 Million - $1.6 Million
29,343 Added 55.61%
82,106 $4.08 Million
Q4 2020

Feb 03, 2021

BUY
$48.52 - $58.02 $953,126 - $1.14 Million
19,644 Added 59.31%
52,763 $2.64 Million
Q3 2020

Nov 05, 2020

BUY
$53.07 - $61.1 $1.76 Million - $2.02 Million
33,119 New
33,119 $1.82 Million
Q1 2019

May 06, 2019

SELL
$35.49 - $43.02 $1.04 Million - $1.26 Million
-29,375 Closed
0 $0
Q4 2018

Feb 12, 2019

SELL
$36.86 - $41.49 $474,203 - $533,768
-12,865 Reduced 30.46%
29,375 $1.12 Million
Q3 2018

Nov 02, 2018

SELL
$34.76 - $39.72 $1.52 Million - $1.73 Million
-43,635 Reduced 50.81%
42,240 $1.67 Million
Q2 2018

Aug 09, 2018

SELL
$34.55 - $37.05 $797,068 - $854,743
-23,070 Reduced 21.18%
85,875 $3.02 Million
Q1 2018

Apr 30, 2018

SELL
$32.97 - $36.63 $906,839 - $1.01 Million
-27,505 Reduced 20.16%
108,945 $3.81 Million
Q4 2017

Feb 02, 2018

BUY
$32.09 - $34.78 $99,799 - $108,165
3,110 Added 2.33%
136,450 $4.74 Million
Q3 2017

Nov 06, 2017

BUY
$28.96 - $34.0 $3.86 Million - $4.53 Million
133,340
133,340 $4.52 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.